Search

Displaying results 6521 - 6530 of 7687 in total
  1. Drug

    Osanetant

    go.drugbank.com/drugs/DB04872
    Investigational

    In a review of its R&D portfolio, the company announced in August 2005 that it would cease any further development of osanetant. … This follows an earlier decision to discontinue development of eplivanserin for schizophrenia.

  2. Drug

    WIN 55212-2

    go.drugbank.com/drugs/DB13950
    Experimental

    WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but has an entirely different chemical

    Synonyms: (2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate
  3. Drug

    XL019

    go.drugbank.com/drugs/DB05243
    Investigational

    An IND for XL019 was filed by Exelixis in May 2007.

  4. Drug

    Telapristone acetate

    go.drugbank.com/drugs/DB05253
    Investigational

    Telapristone acetate, an orally-available, selective progesterone receptor modulator, is in development to alleviate symptoms associated with both uterine fibroids and endometriosis.

  5. Drug

    IRX-2

    go.drugbank.com/drugs/DB05643
    Investigational

    It is being investigated to promote or enhance an anti-cancer immune response.

  6. Drug

    Maclura tricuspidata whole

    go.drugbank.com/drugs/DB14264
    Investigational

    It is not an approved drug.

  7. Drug

    Tribulus terrestris root

    go.drugbank.com/drugs/DB14266
    Investigational

    It is not an approved drug.

  8. Drug

    Phellinus linteus mycelium

    go.drugbank.com/drugs/DB14282
    Investigational

    It is not an approved drug.

  9. Drug

    Panax quinquefolius whole

    go.drugbank.com/drugs/DB14296
    Investigational

    It is not an approved drug.

  10. Drug

    Mucuna pruriens seed

    go.drugbank.com/drugs/DB14299
    Investigational

    It is not an approved drug.